Cargando…

miR-505 suppresses prostate cancer progression by targeting NRCAM

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469085/ https://www.ncbi.nlm.nih.gov/pubmed/32945518 http://dx.doi.org/10.3892/or.2020.7696

Ejemplares similares

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017)

The targeting of MTDH by miR-145-5p or miR-145-3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells
por: Pan, Dong, et al.
Publicado: (2023)

Corrigendum to “miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1”
por: Jia-yuan, Xu, et al.
Publicado: (2020)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2022)

KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells
por: Liu, Yunlu, et al.
Publicado: (2022)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R
por: Ren, Liang, et al.
Publicado: (2019)

miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
por: Li, An, et al.
Publicado: (2019)

miR-382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor-associated macrophages by targeting PGC-1α
por: Zhou, Hua, et al.
Publicado: (2022)

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2023)

miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2019)

miR-29a inhibits human retinoblastoma progression by targeting STAT3
por: Liu, Shu, et al.
Publicado: (2021)

miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
por: Ye, Conglin, et al.
Publicado: (2021)

miR‐505 inhibits proliferation of osteosarcoma via HMGB1
por: Li, Guangzhang, et al.
Publicado: (2020)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

Cataracts and NrCAM
por: Dove, Alan W.
Publicado: (2001)

Corrigendum to “miR-1-Mediated Induction of Cardiogenesis in Mesenchymal Stem Cells via Downregulation of Hes-1”
por: Huang, Feng, et al.
Publicado: (2016)

Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer
por: Tang, Yubo, et al.
Publicado: (2019)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
por: Nie, Wenyuan, et al.
Publicado: (2019)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis [Corrigendum]
Publicado: (2021)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

Long Non-coding RNA KTN1-AS1 Targets miR-505 to Promote Glioblastoma Progression
por: Guo, Kai, et al.
Publicado: (2023)

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613 [Corrigendum]
Publicado: (2021)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
por: Wang, Hao, et al.
Publicado: (2021)

Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2023)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

The Effect of miR-505-5p on Inhibition of Serum Uromodulin Ameliorates Myocardial Inflammation and Apoptosis Induced by Ischemia-Reperfusion
por: He, Dongsheng, et al.
Publicado: (2022)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

Corrigendum to: MiR‐449a exerts tumor‐suppressive functions in human glioblastoma by targeting Myc‐associated zinc‐finger protein
Publicado: (2022)

Corrigendum to “miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14”
por: Wang, Tong, et al.
Publicado: (2022)

Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression
por: Bullock, M D, et al.
Publicado: (2013)

miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1
por: Xu, Juan, et al.
Publicado: (2017)

Corrigendum to “Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway” [Redox Biol. 18 (2018) 124–137]
por: Zhao, Xiao-Juan, et al.
Publicado: (2019)

Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
por: Huang, Suning, et al.
Publicado: (2020)

The long noncoding RNA DLGAP1‐AS2 facilitates cholangiocarcinoma progression via miR‐505 and GALNT10
por: Liu, Zhao, et al.
Publicado: (2020)

Dendritic cell-derived exosomal miR-494-3p promotes angiogenesis following myocardial infarction
por: Liu, Haibo, et al.
Publicado: (2022)

Corrigendum to “Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer” [Transl Oncol 12 (8) (2019) 1038–1044]
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tji4htnqs8crepkpic6goktip8